HP
Hikari Power Portfolio holdings
AUM
$1.2B
This Quarter Return
+1.74%
1 Year Return
+14.18%
3 Year Return
+56.59%
5 Year Return
+122.08%
10 Year Return
+191.59%
AUM
$928M
AUM Growth
+$928M
(-2.7%)
Cap. Flow
-$39M
Cap. Flow
% of AUM
-4.2%
Top 10 Holdings %
Top 10 Hldgs %
59.54%
Holding
150
New
27
Increased
25
Reduced
20
Closed
35
Top Buys
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
$9.23M |
| 2 |
Altria Group
MO
|
$4.76M |
| 3 |
Johnson & Johnson
JNJ
|
$3.15M |
| 4 |
Medtronic
MDT
|
$2.53M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
$2.34M |
Top Sells
| 1 |
IBM
IBM
|
$16.8M |
| 2 |
RTX Corp
RTX
|
$11.9M |
| 3 |
General Mills
GIS
|
$11.2M |
| 4 |
GE Aerospace
GE
|
$10.3M |
| 5 |
Wells Fargo
WFC
|
$4.66M |
Sector Composition
| 1 | Financials | 38.49% |
| 2 | Healthcare | 20.48% |
| 3 | Industrials | 9.59% |
| 4 | Consumer Staples | 5.51% |
| 5 | Materials | 5.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Viking Therapeutics
VKTX
$3.02B
| $415K | 0.04% |
50,000
| – | – |
|
77
Ecolab
ECL
$77.5B
| $415K | 0.04% |
2,100
| – | – |
|
78
Mersana Therapeutics
MRSN
$34.8M
| $365K | 0.04% |
90,246
| – | – |
|
79
Carisma Therapeutics
CARM
$15.5M
| $318K | 0.03% |
211,855
-200
| -0.1% | -$300 |
|
|
DO
80
DELISTED
Diamond Offshore Drilling
DO
| $312K | 0.03% |
35,200
| – | – |
|
|
ERUS
81
DELISTED
iShares MSCI Russia ETF
ERUS
| $309K | 0.03% |
7,850
| – | – |
|
82
Thermo Fisher Scientific
TMO
$183B
| $294K | 0.03% |
+1,000
| New | +$294K |
|
83
Aldeyra Therapeutics
ALDX
$350M
| $267K | 0.03% |
44,520
| – | – |
|
|
SPHS
84
DELISTED
Sophiris Bio, Inc.
SPHS
| $254K | 0.03% |
300,900
+100,000
| +50% | +$84.4K |
|
|
FSTX
85
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $226K | 0.02% |
61,336
+7,800
| +15% | +$28.7K |
|
86
Emcor
EME
$28.1B
| $226K | 0.02% |
+2,570
| New | +$226K |
|
87
ManpowerGroup
MAN
$1.89B
| $222K | 0.02% |
+2,300
| New | +$222K |
|
88
H&R Block
HRB
$6.83B
| $222K | 0.02% |
7,590
-2,170
| -22% | -$63.5K |
|
89
Cencora
COR
$57.2B
| $221K | 0.02% |
+2,590
| New | +$221K |
|
90
Prestige Consumer Healthcare
PBH
$3.29B
| $220K | 0.02% |
+6,960
| New | +$220K |
|
91
Synchrony
SYF
$28.1B
| $218K | 0.02% |
+6,300
| New | +$218K |
|
92
Nektar Therapeutics
NKTR
$543M
| $210K | 0.02% |
+5,900
| New | +$210K |
|
93
Innoviva
INVA
$1.32B
| $209K | 0.02% |
+14,340
| New | +$209K |
|
94
Applied Materials
AMAT
$124B
| $208K | 0.02% |
+4,630
| New | +$208K |
|
|
MTOR
95
DELISTED
MERITOR, Inc.
MTOR
| $205K | 0.02% |
+8,470
| New | +$205K |
|
96
Advanced Energy
AEIS
$5.48B
| $205K | 0.02% |
+3,650
| New | +$205K |
|
97
HP
HPQ
$26.8B
| $204K | 0.02% |
+9,790
| New | +$204K |
|
|
WW
98
DELISTED
WW International
WW
| $202K | 0.02% |
+10,600
| New | +$202K |
|
|
CALA
99
DELISTED
Calithera Biosciences, Inc
CALA
| $195K | 0.02% |
50,000
| – | – |
|
100
Corcept Therapeutics
CORT
$7.52B
| $187K | 0.02% |
+16,790
| New | +$187K |
|